A recent systematic meta-analysis of 19 different studies showed that the expression of AR is favorable prognostic marker in early stage breast cancer, irrespective the ER status, with approximately a doubling of OS at 3 ad 5 years [46]. The gene discussed is AR; the disease is breast carcinoma.